Arkolith/Insider Trading/EPZM/Form 4

Conroy Kevin T

DirectorEpizyme, Inc. (EPZM) · full profile →Form 4 · filed May 19, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 17, 2022Grant(A)9K—$052K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 17, 2022Grant(A)41K—$041K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-018826) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML